LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Search

Rigel Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

50.85 2.91

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

50.85

Max

51.57

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

-7.85% downside

Naujienos nuotaikos

By Acuity

50%

50%

168 / 374 reitingas Healthcare

Rigel Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-27 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

2025-11-27 15:32; UTC

Įsigijimai, susijungimai, perėmimai

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

2025-11-27 23:50; UTC

Rinkos pokalbiai

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

2025-11-27 23:50; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-27 16:05; UTC

Rinkos pokalbiai

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

2025-11-27 16:04; UTC

Rinkos pokalbiai

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

2025-11-27 15:54; UTC

Įsigijimai, susijungimai, perėmimai

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

2025-11-27 15:44; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse: No Certainty Talks Will Result in Transaction

2025-11-27 15:43; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

2025-11-27 15:42; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

2025-11-27 15:41; UTC

Įsigijimai, susijungimai, perėmimai

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

2025-11-27 15:11; UTC

Rinkos pokalbiai

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

2025-11-27 14:26; UTC

Rinkos pokalbiai

Hermes' Outperformance Gap Could Narrow -- Market Talk

2025-11-27 14:11; UTC

Rinkos pokalbiai

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

2025-11-27 14:11; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-11-27 13:35; UTC

Rinkos pokalbiai

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

2025-11-27 13:33; UTC

Rinkos pokalbiai

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

2025-11-27 13:22; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-11-27 13:22; UTC

Rinkos pokalbiai

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

2025-11-27 13:17; UTC

Rinkos pokalbiai

LVMH Should Be Able to Recover Next Year -- Market Talk

2025-11-27 11:13; UTC

Rinkos pokalbiai

European Gas Prices Come Under Pressure -- Market Talk

2025-11-27 11:07; UTC

Uždarbis

Genting: Positive About Prospects Over Longer Term

2025-11-27 11:06; UTC

Uždarbis

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

2025-11-27 11:04; UTC

Uždarbis

Genting: International Travel Demand Expected to Remain Resilient

2025-11-27 11:04; UTC

Uždarbis

Genting: Global Growth Expected to Remain Subdued

2025-11-27 11:04; UTC

Uždarbis

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

2025-11-27 10:59; UTC

Uždarbis

Genting Bhd 3Q Net Profit Fell 86% on Year

2025-11-27 10:58; UTC

Uždarbis

Genting Bhd 3Q Rev Rose 14% on Year

2025-11-27 10:56; UTC

Uždarbis

Genting Bhd 3Q Net MYR30.3M

2025-11-27 10:56; UTC

Uždarbis

Genting Bhd 3Q EPS MYR0.0079

Akcijų palyginimas

Kainos pokytis

Rigel Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

-7.85% į apačią

12 mėnesių prognozė

Vidutinis 45.67 USD  -7.85%

Aukščiausias 57 USD

Žemiausias 38 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Rigel Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

2

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

168 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

$

help-icon Live chat